Fetal-neonatal alloimmune thrombocytopenia and unexpected Glanzmann thrombasthenia carrier: Report of two cases

Transfusion

Volumn 45, Issue 4, 2005, Pages 550-553

  Jallu, Vincent ^a   Bianchi, Frédéric ^a   Kaplan, Cécile ^a  

^a INSTITUT NATIONAL DE LA TRANSFUSION SANGUINE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ALLOANTIGEN; GLYCOPROTEIN IIB; GLYCOPROTEIN IIIA; MEMBRANE PROTEIN; THROMBOCYTE ANTIGEN;

ALLOIMMUNIZATION; ARTICLE; DNA SEQUENCE; FETOPLACENTAL UNIT; GENE AMPLIFICATION; GENOTYPE; GLANZMANN DISEASE; HUMAN; PHENOTYPE; POINT MUTATION; POLYMERASE CHAIN REACTION; THROMBOCYTOPENIA;

ANTIGENS, HUMAN PLATELET; DIAGNOSTIC ERRORS; ERYTHROBLASTOSIS, FETAL; FEMALE; GENOTYPE; HETEROZYGOTE; HUMANS; INFANT, NEWBORN; PHENOTYPE; POINT MUTATION; PREGNANCY; PREGNANCY COMPLICATIONS, HEMATOLOGIC; THROMBASTHENIA; THROMBOCYTOPENIA;

EID: 17044429381     PISSN: 00411132     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.0041-1132.2005.04275.x     Document Type: Article

References (15)

1. Dreyfus M, Kaplan C, Verdy E, et al. Frequency of immune thrombocytopenia in newborns: a prospective study. Blood 1997;89:4402-6.
2. Williamson LM, Hackett G, Rennie J, et al. The natural history of fetomaternal alloimmunization to the platelet-specific antigen HPA-1a (PLAI, Zwa) as determined by antenatal screening. Blood 1998;92:2280-7.
3. Kiefel V, Santoso S, Weisheit M, et al. Monoclonal antibody-specific immobilization of platelet antigens (MAIPA): a new tool for the identification of platelet-reactive antibodies. Blood 1987;70:1722-6.
4. Kroll H, Kiefel V, Santoso S. Clinical aspects and typing of platelet alloantigens. Vox Sang 1998;74(Suppl 2):345-54.
5. French DL, Coller B. Hematologically important mutations: Glanzmann thrombasthenia. Blood Cells Mol Dis 1997;23:39-51.
6. Jallu V, Meunier M, Bremert M, et al. A new platelet polymorphism Duva+, localized within the RGD binding domain of glycoprotein IIIa, is associated with neonatal thrombocytopenia. Blood 2002;99:4449-56.
7. Klüter H, Fehlau K, Panzer S, et al. Rapid typing for human platelet antigen systems-1, -2, -3, and -5 by PCR amplification with sequence specific primers. Vox Sang 1996;71:121-5.
8. Quintanar A, Jallu V, Legros Y, et al. Human platelet antigen genotyping using a fluorescent SSCP technique with an automatic sequencer. Br J Haematol 1998;103:437-44.
9. Kato A, Yamamoto K, Miyazaki S, et al. Molecular basis for Glanzmann's thrombasthenia (GT) in a compound heterozygote with glycoprotein lib gene: a proposal for the classification of GT based on the biosynthetic pathway of glycoprotein IIb-IIIa complex. Blood 1992;79:3212-8.
10. Jin Y, Dietz HC, Nurden A, et al. Single-strand conformation polymorphism analysis is a rapid and effective method for the identification of mutations and polymorphisms in the gene for GP IIIa. Blood 1993;82:2281-8.
11. Morel-Kopp MC, Clemenceau S, Aurousseau MH, et al. Human platelet alloantigen typing: PCR analysis is not a substitute for serological methods. Transfus Med 1994;4:9-14.
12. George JN, Caen JP, Nurden AT. Glanzmann's thrombasthenia: the spectrum of clinical disease. Blood 1990;75:1383-95.
13. 2 allelic form IIIa: Implications for the correlation of correlation of serologic versus genotypic analysis of human platelet alloantigens. Blood 1996;88:3831-6.
14. Morel-Kopp MC, Lecompte T, Schlegel N, et al. Use of murine monoclonal antibodies to study thrombopathies related to GP IIb-IIIa complexes. In: Kaplan-Gouet C, Schlegel N, Salmon Ch, et al., eds. Platelet immunology: fundamental and clinical aspects. Paris: John Libbey-Eurotext/Ed.INSERM; 1991. p. 161-71.
15. Kroll H, Santoso S, Krämer V, Mueller-Eckhardt C, Kiefel V. Frequency of Glanzmann's thrombasthenia carriers estimated by discrepancies in platelet alloantigen typing strategies [abstract]. Blood 1996;88(Suppl 1):320a.